Literature DB >> 15587340

Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.

B Gressens1, P Gohy.   

Abstract

Pericarditis due to interferon alpha therapy during treatment for chronic hepatitis C. We report a patient with pericarditis during therapy with interferon alpha 2b for chronic hepatitis C viral infection. We review interferon alpha therapy and hepatitis C virus side-effects on the cardiovascular system.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15587340

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN： 1784-3227            Impact factor:   1.316


  8 in total

1.  Interferon-α and pericardial injury: a case report and literature review.

Authors:  Fayaz A Hakim; Sujata Singh; Anil Pandit; Jorge R Alegria; John Camoriano; Melissa L Stanton; Farouk Mookadam
Journal:  Heart Asia       Date:  2014-04-16

2.  Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C.

Authors:  Kazuaki Nishio; Takeshi Konndo; Shunichi Okada; Machiko Enchi
Journal:  World J Hepatol       Date:  2010-09-27

3.  Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - case report.

Authors:  Cristina Popescu; Victoria Arama; Smaranda Gliga
Journal:  BMC Gastroenterol       Date:  2011-03-31       Impact factor: 3.067

Review 4.  Treatment of hepatitis C virus infection and associated vascular complications: a literature review.

Authors:  Reza Karbasi-Afshar
Journal:  Iran J Med Sci       Date:  2014-05

5.  Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model.

Authors:  Rebeca Blázquez; Francisco Miguel Sánchez-Margallo; Verónica Crisóstomo; Claudia Báez; Juan Maestre; Verónica Álvarez; Javier G Casado
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

6.  Interferon related pericarditis: Review.

Authors:  Kazuaki Nishio; Tsutomu Arase; Hiroko Tada; Hideaki Tachibana
Journal:  World J Cardiol       Date:  2017-06-26

7.  Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.

Authors:  Iram Gull; Muhammad Shahbaz Aslam; Imran Tipu; Roohi Mushtaq; Tehseen Zamir Ali; Muhammad Amin Athar
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

Review 8.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.